Cracking the Genome: Inside the Race to Unlock Human DNA

by Kevin Davis and Kevin Davies

Book Overview

In 1953, James Watson and Francis Crick unveiled the double helix structure of DNA. The discovery was a profound moment in the history of science, but solving the structure of the genetic material did... This description may be from another edition of this product.

• Format: Hardcover
• Language: English
• ISBN: 0743204794
• ISBN13: 9780743204798
• Release Date: January 2001
• Publisher: Free Press
• Length: 310 Pages
• Weight: 1.24 lbs.
• Dimensions: 1.2" x 6.3" x 9.5"

Customer Reviews

Highly Recommended!

Ken Davies has written an informed observer's account of the passionate race to solve what some believe to be the most profound scientific riddle of our era: decoding the human genome. His book is an undertaking of ambitious scope: He aims to paint the personalities in all their human colors and offer an accurate historical account, while also drilling deep enough into the research to do justice to the science. He does a beautiful job of suggesting the profound personal motivations of the two protagonists of the drama, scientists Francis Crick and maverick scientist J. Craig Venter. Short of earning your Ph.D. in molecular science, this may be as close as you ever get to understanding what the hoopla was really all about. We [...] recommend Davies' book as a must for savvy thinkers in the biotech business, and an enlightening read for the rest of us mere (genetically flawed) mortals.

One of the most important stories of our time. A must-read

Although science is not everyone's favorite subject, the story of the sequencing of the human genome is of importance to every person on the planet.The story of the Human Genome Project itself, which is an illustration of how the private sector can succeed where government funded projects have difficulties, is interesting in itself. Even outside of the medical and ethical implications, this story is worth reading for that information alone.But where this book really provides important food for thought is in the medical and ethical arena. It is now possible to find the location and coding for diseases and potential diseases using this information. How will we use this information? To create cures for devastating degenerative diseases like Huntington's, to find cures for the incurable? Or will we use it to deny medical care to people deemed potential insurance risks.One thing that came out of the study was the surprising small number of genes that comprise the genome--one third the number that had long been predicted. Clearly, the genome is an instruction set, and the blueprints to build a human, and the errors that create disease, are written in how the genes are interpreted by the biological mechanism.How we should utilize this information, for good or evil, in years to come will surely be some of the most controversial and important discussions we will have. This book is an excellent place to start in order to understand the basis of this world-shaking achievement.

Very interesting read

I am an avid popular science reader and very much enjoyed reading this book--a nice blend of science and more personal aspects in the genome and very readable! I also thought the discussions of the genome and its impact on disease were useful. I just finished reading the book "Decoding Darkness" on the genes that cause Alzheimer's and got a much deeper appreciation of how the human genome being decoded is so helpful -- Davies'book really put the big picture of the genome in perspective -- so it was fun to happen to read these back to back -- both are highly recommended!

Readable and accurate view of events

This is an extremely readable account of personalities and events that have occurred in the genome field during the last decade (plus some). It is basically two books. One is the story about the politics and events surrounding the public and private efforts to sequence the human genome. The other is a brief survey of medical genetics to put the genome sequencing effort in context. By medical genetics I mean the genetically unusual and useful individuals and populations that geneticists study to find and understand disease genes. For example: the Huntington's disease story. The medical genetics stories have all been reported on in other books of this type but the comprehensive account of the public/private genome efforts is worth reading to those who have been following the magazine and newspaper accounts. It essentially collates all of the stories and news bites of the last several years into a single coherent narrative. As an earlier review noted it is short on science but that is what makes the book a good read. You can pick up the minimal science facts necessary from many other books and web sites.I've been an engineer in the DOE genome program for about 10 years now. Many of the stories in the book I've heard first hand from people who were either in the room or were participants in the events. It is as accurate a version as any I've seen. Usually I shy away from these types of books but this one is a must read if you really want to get beyond the hype of the popular press.

An Important Accomplishment Behind, Greater Challenges Ahead

This book is a very important contribution to both the scientific and the business literature for the lay person. It provides an overview of the development of our understanding of heredity from Gregor Mendel's pioneering work until the human genome was 99 percent sequenced in early 2000. The book then looks beyond that remarkable success to outline the even greater and more challenging work ahead. By contrasting the expensive, slow public effort with the agile, rapid progress of private industry, the book is also a cautionary tale about how to accelerate scientific progress through private incentives. Many books about scientific advances focus a lot on the science. Cracking the Genome does that as well, but the book is improved by considering the personalities of the people involved, their interactions, public policy questions, ethical discussions, and science fiction like speculations about the eventual shape of the scientific applications of this work. These perspectives are valuable for expanding your understanding, as well as for making the book much more interesting.Frankly, the book could have used a little more science. I recommend that you read the recent book, Genome, as well which will give you a more detailed understanding of the underlying structure of the genome and how it works. The Human Genome Project was originally conceived of as a public project funded by three billion dollars in taxpayer money taking 15 years. At the half-way point in the project, only 4 percent of the human genome had been sequenced. A one-time NIH (National Institutes of Health) neuroscience researcher, J. Craig Ventor, had been arguing unsuccessfully for a computer-based "brute force" method as faster and cheaper. All of the M.D.s (who can be pardoned for not understanding the potential of math and computers) couldn't understand why it might work, and Ventor was vilified. He went off to found a private institute that made great progress using his methods. Then in 1998, he joined Perkin-Elmer. From there, he was able to complete the sequencing in 2 years using three hundred million dollars. So the work got done for about a tenth of the cost and about 8 times faster than the planned alternative. The public project was given vast increases in funds to try to keep up with Ventor's group, and both projects were completed within a few months. Victory was proclaimed at the White House, and both groups honored in June 2000. One of the most interesting parts of the book is that the controversy over patenting genes was started by NIH under Bernadine Healy. In the public press, this has been treated as an intellectual grab by private industry. In this light, it seems like a response to what the government did. I loved understanding the implications of having sequenced many different living organizations, and also the potential benefits from sequencing proteins and enzymes. Everything fell into place. I suspect that those who invest in biotechn